Tirzepatide Alternatives in Washington
Compare generic and therapeutic alternatives to Tirzepatide (tirzepatide) available at Washington pharmacies. Save up to 38% on your prescription — no insurance required.
Top Alternatives in Washington
Semaglutide (Ozempic/Wegovy)
therapeutic
GLP-1 agonist — well-established, slightly lower weight loss on average
Avg cash price: $940/mo
Compounded tirzepatide
therapeutic
Compounding pharmacy option — available during FDA shortage periods
Avg cash price: $300/mo
Rybelsus (oral semaglutide)
therapeutic
Oral daily tablet — no injection, moderate weight loss
Avg cash price: $870/mo
Washington Prescription Assistance Programs
Apple Health (Washington Medicaid)
Comprehensive prescription drug coverage for Apple Health (Washington State Medicaid) beneficiaries.
Eligibility: Low-income Washington adults up to 138% FPL, children, pregnant women, seniors, and people with disabilities.
Washington Prescription Drug Program (WPDP)
State-negotiated drug discounts for residents without adequate prescription drug coverage. Provides a discount card accepted at most Washington pharmacies.
Eligibility: Washington State residents who lack prescription drug insurance coverage. No income requirements. Available at rx.wa.gov.
Frequently Asked Questions
What is the difference between Mounjaro and Zepbound?
Mounjaro and Zepbound contain identical tirzepatide. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is FDA-approved for chronic weight management/obesity. Same drug, different labelled indication.
How much weight loss can I expect on tirzepatide?
The SURMOUNT trials showed average weight loss of 15–22.5% of body weight on tirzepatide 10–15 mg/week — greater than any other approved weight-loss medication and comparable to bariatric surgery outcomes.
How does tirzepatide differ from semaglutide?
Tirzepatide targets both GLP-1 and GIP receptors; semaglutide only targets GLP-1. The dual mechanism of tirzepatide produces greater average weight loss and HbA1c reduction in head-to-head trials (SURPASS-2).
Is there a cheaper alternative to tirzepatide?
Compounded tirzepatide from licensed pharmacies costs $250–$400/month during FDA shortage periods — 60–75% less than brand Mounjaro/Zepbound. Confirm current shortage status with your pharmacist.
Can Script Unlock help with tirzepatide costs?
Script Unlock connects patients with pharmacies carrying brand Mounjaro/Zepbound and compounding pharmacies offering tirzepatide during shortage periods. Post your prescription to compare bids.